Document is current

Article History

Received: 6 May 2025

Revised: 5 October 2025

Accepted: 25 October 2025

First Online: 14 November 2025

Compliance with ethical standards

:

: The scientific guarantor of this publication is Fujun Yu.

: None of the authors have identified a conflict of interest.

: No complex statistical methods were necessary for this paper.

: Written informed consent was waived by the Institutional Review Board.

: Institutional Review Board approval was obtained.

: 43 of 744 patients in the current study have been previously reported in Yu et al [ ]. This earlier report evaluated the outcomes of ablation in patients experiencing decompensated events and identified a high incidence of liver-related complications, with a rate of 12.1%. The current study evaluated outcomes of ablation in recompensated or compensated cirrhosis and reported a low incidence of liver-related complications in recompensation patients, with a rate of 1.4%. No postoperative liver failure or decompensated events were observed in the recompensation group.

: